Afrocentric Investment (JSE:ACT) Common Stock: R8 Mil (As of Dec. 2025)


JSE:ACT Afrocentric Investment Corp Ltd JSE:ACT
52 GF Score
Price R0.79
GF Value R2.09
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Afrocentric Investment Common Stock?

Afrocentric Investment JSE:ACT 52 Common Stock is R8 Mil as of Dec. 2025. GuruFocus rates JSE:ACT with a GF Score™ of 52/100 and a GF Value™ of R2.09 (Possible Value Trap). The stock has 6 warning signs investors should review.

Afrocentric Investment's quarterly common stock declined from Dec. 2024 (R21 Mil) to Jun. 2025 (R21 Mil) and declined from Jun. 2025 (R21 Mil) to Dec. 2025 (R8 Mil).

Afrocentric Investment's annual common stock declined from Jun. 2023 (R21 Mil) to Jun. 2024 (R8 Mil) but then increased from Jun. 2024 (R8 Mil) to Dec. 2025 (R8 Mil).

Afrocentric Investment Common Stock Historical Data

* Premium members only.

The historical data trend for Afrocentric Investment's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Afrocentric Investment Common Stock Chart

Afrocentric Investment Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.89 18.91 21.29 8.18 8.21

Afrocentric Investment Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.32 8.18 21.32 21.32 8.21
JSE:ACT
52GF Score
Afrocentric Investment Corp Ltd JSE:ACT
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Afrocentric Investment Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of R8 Mil mean?
Afrocentric Investment (JSE:ACT) has a Common Stock of R8 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Afrocentric Investment and its competitors.
Is Afrocentric Investment's Common Stock too high?
Afrocentric Investment's current Common Stock is R8 Mil. Overall, Afrocentric Investment has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Afrocentric Investment's Common Stock compare to HCA and THC?
Afrocentric Investment's Common Stock of R8 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Healthcare Providers & Services company?
A good Common Stock depends on the Healthcare Providers & Services industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Afrocentric Investment and its competitors. Afrocentric Investment's current Common Stock is R8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afrocentric Investment stock overvalued right now?
Based on GuruFocus' analysis, Afrocentric Investment (JSE:ACT) is currently considered Possible Value Trap. The stock's GF Value™ is R2.09, compared to a current price of R0.79 — trading 62.2% below its estimated fair value. The current Common Stock is R8 Mil. Afrocentric Investment's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Afrocentric Investment (JSE:ACT), the current Common Stock is R8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Afrocentric Investment (JSE:ACT) Overvalued in 2026?

Based on GuruFocus' analysis, Afrocentric Investment stock appears to be undervalued. The current stock price of R0.79 is trading 62.2% below its estimated GF Value™ of R2.09. GuruFocus considers Afrocentric Investment to be Possible Value Trap.

Key valuation signals for JSE:ACT:

  • Common Stock: R8 Mil
  • GF Value™: R2.09 vs. price of R0.79 (62.2% below fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the JSE:ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Afrocentric Investment Business Description

Address 37 Conrad Road, Florida North, Roodepoort, ZAF, 1709
Afrocentric Investment Corp Ltd is an investment holding company providing specialised services and products to the public and private healthcare sectors. It focuses on making quality healthcare accessible and affordable to members and beneficiaries, with the principal objective of ensuring the delivery of efficient health management services and the distribution of quality products. Its business segments include Healthcare SA, comprising medical scheme administration and health risk management services; Healthcare Retail, comprising pharmaceutical sales and services; Healthcare Africa, comprising healthcare services outside South Africa in Namibia and Mauritius; and IT-related services predominantly within South Africa. It operates across South Africa, Botswana, Mauritius, and Namibia.
52GF Score

Get the complete analysis for JSE:ACT

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R0.79
Price
R2.09
GF Value